The first N-heterocyclic carbene-based nickel catalyst for C− S coupling

Y Zhang, KC Ngeow, JY Ying - Organic letters, 2007 - ACS Publications
We have developed the first N-heterocyclic carbene (NHC)-based transition metal catalysts
for C−S coupling reactions. Ni−NHC catalysts showed good to excellent activities toward …

BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export

KC Ngeow, HJ Friedrichsen, L Li… - Proceedings of the …, 2018 - National Acad Sciences
The close integration of the MAPK, PI3K, and WNT signaling pathways underpins much of
development and is deregulated in cancer. In principle, combinatorial posttranslational …

[HTML][HTML] Complementing tissue testing with plasma mutation profiling improves therapeutic decision-making for patients with lung cancer

Y Choudhury, MH Tan, JL Shi, A Tee, KC Ngeow… - Frontiers in …, 2022 - frontiersin.org
Background Tissue biopsy is an integral part of the diagnostic approach to lung cancer. It is
however invasive and limited by heterogeneity. Liquid biopsies may complement tissue …

[HTML][HTML] Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA

J Poh, KC Ngeow, M Pek, KH Tan, JS Lim, H Chen… - Plos one, 2022 - journals.plos.org
Next-generation sequencing of circulating tumor DNA presents a promising approach to
cancer diagnostics, complementing conventional tissue-based diagnostic testing by enabling …

A cell-free RNA-based next-generation sequencing (NGS) assay for the detection of actionable gene fusions in patients with non–small cell lung cancer (NSCLC).

…, CY Cher, JM Ho, C Chan, MW Teh, KC Ngeow… - 2022 - ascopubs.org
3040 Background: Gene fusions and alternate RNA splice forms represent clinically actionable
driver and resistance-conferring alterations in NSCLC and other cancers. Where tissue …

Longitudinal tracking of ALK-positive lung cancer from plasma using circulating-tumor RNA and circulating-tumor DNA in the BRIGHTSTAR clinical trial.

…, M Antonoff, X Le, JC Tu, M Pek, J Poh, KC Ngeow… - 2023 - ascopubs.org
e21072 Background: While the administration of specific tyrosine-kinase inhibitors (TKIs) in
ALK-fusion positive lung cancer has led to significant improvement in clinical outcomes, …

Complementing tissue testing with plasma mutation profiling improves therapeutic decision making for lung cancer patients

Y Choudhury, MH Tan, JL Shi, A Tee, KC Ngeow… - medRxiv, 2021 - medrxiv.org
Background Tissue biopsy is an integral part of the diagnostic approach to lung cancer. It is
however invasive and associated with limitations of tissue heterogeneity. Liquid biopsies …

Comprehensive molecular profiling of advanced cancers in a real-world setting using an ultrasensitive amplicon-based next-generation sequencing (NGS) liquid …

J Poh, KC Ngeow, M Pek, D Tan, JS Lim, Y Choudhury - 2021 - ascopubs.org
3062 Background: Molecular profiling of circulating tumor DNA (ctDNA) by NGS has
demonstrated the value of liquid biopsy in informing treatment decisions and monitoring disease …

P1. 13-06 Plasma Cell-free RNA Sequencing Enables Sensitive Detection of Lung Cancer

…, CY Cher, JM Ho, MH Tan, KC Ngeow - Journal of Thoracic …, 2023 - jto.org
Methods To determine lung cancer-associated gene expression signatures in cfRNA, an
amplicon panel incorporating molecular barcoding for error-suppression was designed to target …

ETC159, a porcupine inhibitor, exhibits synergism with PI3K inhibitors in 3-dimensional cell culture

S Sepramaniam, XH Chew, KC Ngeow, MA Lee - Cancer Research, 2018 - AACR
Aberrations in WNT signaling, a pathway regulated by a family of secreted glycoproteins known
as WNTs, is implicated as a cause for cancer. Post-translational modification of WNTs by …